BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16022910)

  • 1. Clinical significance of biological differences between cavitated and solid form of squamous cell lung cancer.
    Gasinska A; Kolodziejski L; Niemiec J; Dyczek S
    Lung Cancer; 2005 Aug; 49(2):171-9. PubMed ID: 16022910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients.
    Niemiec J; Kolodziejski L; Dyczek S
    Neoplasma; 2005; 52(3):231-7. PubMed ID: 15875085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cavitated tumor as a clinical subentity in squamous cell lung cancer patients.
    Kolodziejski LS; Dyczek S; Duda K; Góralczyk J; Wysocki WM; Lobaziewicz W
    Neoplasma; 2003; 50(1):66-73. PubMed ID: 12687281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of epidermal growth factor receptor in surgically treated squamous cell lung cancer patients.
    Niemiec J; Kołodziejski L; Dyczek S; Gasińska A
    Folia Histochem Cytobiol; 2004; 42(2):111-8. PubMed ID: 15253134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
    Gasinska A; Urbanski K; Gruchala A; Biesaga B; Kojs Z
    Neoplasma; 2002; 49(6):379-86. PubMed ID: 12584585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma.
    Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY
    BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of EGF receptor expression in early glottic cancer.
    Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M
    Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.
    Brasanac D; Boricic I; Todorovic V; Tomanovic N; Radojevic S
    Br J Dermatol; 2005 Dec; 153(6):1166-75. PubMed ID: 16307653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome.
    Etienne MC; Formento JL; Lebrun-Frenay C; Gioanni J; Chatel M; Paquis P; Bernard C; Courdi A; Bensadoun RJ; Pignol JP; Francoual M; Grellier P; Frenay M; Milano G
    Clin Cancer Res; 1998 Oct; 4(10):2383-90. PubMed ID: 9796969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa.
    Maiorano E; Favia G; Maisonneuve P; Viale G
    J Pathol; 1998 Jun; 185(2):167-74. PubMed ID: 9713343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Ki-67 in squamous cell carcinoma of the penis.
    Berdjis N; Meye A; Nippgen J; Dittert D; Hakenberg O; Baretton GB; Wirth MP
    BJU Int; 2005 Jul; 96(1):146-8. PubMed ID: 15963138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIB-1 labeling index as a prognostic indicator for survival in patients with FIGO stage IB squamous cell carcinoma of the cervix.
    Ho DM; Hsu CY; Chiang H
    Gynecol Oncol; 2000 Jan; 76(1):97-102. PubMed ID: 10620448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation state EGFR and STAT-3 as prognostic markers in resected non-small cell lung cancer.
    Cortas T; Eisenberg R; Fu P; Kern J; Patrick L; Dowlati A
    Lung Cancer; 2007 Mar; 55(3):349-55. PubMed ID: 17161498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.